Parkinson's Disease "Breakthrough" Promises Hope—But Is Big Pharma Suppressing a $5 Cure?
Reports are circulating that a simple, low-cost compound—widely available for under $5 per dose—has shown "remarkable" results in reversing early-stage Parkinson's disease symptoms in a small, unreplicated study. Skeptics are asking: if this compound is so effective, why is it being ignored by the major medical journals and pharmaceutical giants who stand to lose billions in lifelong medication sales? Advocates claim patent issues, not science, are blocking the real cure. The question remains: who benefits from keeping this quiet?